Melanoma and Neural System Tumor Syndrome: Unraveling the Genetic Tapestry
Explore how genetic testing helps identify mutations linked to Melanoma and Neural System Tumor Syndrome, aiding early detection, personalized treatment, and family planning.
Brandon Colby, MD
MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
About Brandon
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Education
- BA in Genetics with Honors, University of Michigan · 2000
- MD, Mount Sinai School of Medicine · 2004
- MBA, Stanford University Graduate School of Business · 2007
Affiliations & Memberships
- Affiliate Specialist, American College of Medical Genetics and Genomics (ACMG)
- Associate, American College of Preventive Medicine (ACPM)
- Member, National Society of Genetic Counselors (NSGC)
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Articles by Brandon
Melanoma, Cutaneous Malignant: Navigating the Genetic Roadmap to Susceptibility
Explore the role of genetic testing in assessing melanoma risk, guiding personalized prevention, informing treatment, and aiding family planning decisions.
Mapping Melanoma: Understanding Genetic Testing for Cutaneous Malignant Susceptibility to Melanoma, Type 2
Explore how genetic testing aids in early detection and personalized treatment of cutaneous malignant melanoma, focusing on MCMS2 risk assessment and prevention.
Melorheostosis: Understanding the Genetic Blueprint of a Rare Bone Disorder
Explore the genetic insights into melorheostosis, a rare bone disorder. Learn how genetic testing aids in diagnosis and personalized treatment strategies.
Meniere Disease: Decoding the Mysteries of the Inner Ear
Explore the impact of genetic testing on Meniere disease: improving diagnosis, identifying genetic markers, and personalizing treatment for better outcomes.
Metachondromatosis: Unlocking the Mysteries of a Rare Bone Disorder through Genetic Testing
Unlock rare bone disorder insights with genetic testing for metachondromatosis. Early diagnosis, personalized treatments, and family planning become possible.
Metaphyseal Chondrodysplasia, Jansen Type: Mapping Genetic Testing for a Rare Skeletal Disorder
Explore how genetic testing aids in diagnosing, managing, and understanding Jansen type metaphyseal chondrodysplasia, a rare skeletal disorder linked to PTH1R mutations.
Metaphyseal Chondrodysplasia, Schmid Type: Genetic Testing's Role in Diagnosis and Management
Uncover how genetic testing aids in diagnosing Metaphyseal Chondrodysplasia, Schmid Type. Explore its role in treatment, family planning, and advancing research today.